On December 6, 2024, CVS Health announced the pricing of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. The offer, initiated on December 2, 2024, is open to all registered holders of the notes. The Reference Yield is set at 4.434% with a Total Consideration of $998.22 per $1,000 principal amount.The tender offer is subject to conditions outlined in the Offer to Purchase, with a settlement date expected on December 11, 2024. Holders will receive accrued interest up to the settlement date. Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers.CVS Health reserves the right to amend or terminate the offer. The tender offer is not contingent on a minimum principal amount being tendered but is subject to a financing condition.

On December 6, 2024, CVS Health announced the pricing of its cash tender offer for any and all of its 4.100% Senior Notes due 2025. The offer, initiated on December 2, 2024, is open to all registered holders of the notes. The Reference Yield is set at 4.434% with a Total Consideration of $998.22 per $1,000 principal amount.The tender offer is subject to conditions outlined in the Offer to Purchase, with a settlement date expected on December 11, 2024. Holders will receive accrued interest up to the settlement date. Barclays Capital Inc. and Mizuho Securities USA LLC are acting as Dealer Managers.CVS Health reserves the right to amend or terminate the offer. The tender offer is not contingent on a minimum principal amount being tendered but is subject to a financing condition.